UnitedHealth Group, Eli Lilly and Company, Hims & Hers Health, Walmart, Incannex Healthcare, AbbVie, and Tempus AI are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares in publicly traded companies operating within the healthcare sector—ranging from pharmaceutical and biotechnology firms to medical device manufacturers and healthcare service providers. They offer investors exposure to advances in medical research and treatments, with performance heavily influenced by clinical trial outcomes, regulatory approvals, and shifts in healthcare policy. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
NYSE UNH traded up $0.02 during trading on Wednesday, reaching $311.40. 21,167,571 shares of the company traded hands, compared to its average volume of 5,037,059. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock's 50 day moving average price is $482.53 and its two-hundred day moving average price is $519.28. UnitedHealth Group has a 1-year low of $309.10 and a 1-year high of $630.73. The company has a market cap of $282.48 billion, a price-to-earnings ratio of 20.09, a P/E/G ratio of 1.37 and a beta of 0.56.
Read Our Latest Research Report on UNH
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
LLY stock traded down $27.37 during trading on Wednesday, hitting $718.69. 3,248,733 shares of the stock traded hands, compared to its average volume of 3,550,307. The stock has a market cap of $681.13 billion, a price-to-earnings ratio of 61.37, a P/E/G ratio of 1.40 and a beta of 0.48. Eli Lilly and Company has a one year low of $677.09 and a one year high of $972.53. The company has a 50 day simple moving average of $804.15 and a 200 day simple moving average of $808.91. The company has a current ratio of 1.15, a quick ratio of 0.97 and a debt-to-equity ratio of 2.00.
Read Our Latest Research Report on LLY
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
HIMS traded down $2.30 during midday trading on Wednesday, hitting $61.70. The company had a trading volume of 31,916,679 shares, compared to its average volume of 18,848,284. The company has a market capitalization of $13.81 billion, a PE ratio of 140.23 and a beta of 1.84. The firm's 50-day simple moving average is $33.85 and its 200-day simple moving average is $32.96. Hims & Hers Health has a twelve month low of $13.12 and a twelve month high of $72.98.
Read Our Latest Research Report on HIMS
Walmart (WMT)
Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.
Shares of WMT traded up $0.56 during trading hours on Wednesday, hitting $96.44. 11,631,530 shares of the stock traded hands, compared to its average volume of 17,863,314. Walmart has a 1-year low of $59.44 and a 1-year high of $105.30. The business has a fifty day moving average of $90.70 and a 200-day moving average of $92.16. The company has a current ratio of 0.82, a quick ratio of 0.23 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $771.61 billion, a PE ratio of 40.02, a price-to-earnings-growth ratio of 4.42 and a beta of 0.70.
Read Our Latest Research Report on WMT
Incannex Healthcare (IXHL)
Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
Shares of Incannex Healthcare stock traded up $0.79 on Wednesday, hitting $0.88. 1,144,324,459 shares of the company's stock traded hands, compared to its average volume of 5,092,530. The stock has a market capitalization of $15.70 million, a PE ratio of -0.63 and a beta of 7.67. Incannex Healthcare has a one year low of $0.08 and a one year high of $3.55. The firm's 50-day moving average price is $0.57 and its two-hundred day moving average price is $1.43. The company has a debt-to-equity ratio of 2.47, a current ratio of 1.80 and a quick ratio of 1.65.
Read Our Latest Research Report on IXHL
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
NYSE:ABBV traded down $8.42 on Wednesday, reaching $179.58. The company's stock had a trading volume of 4,878,189 shares, compared to its average volume of 6,171,940. AbbVie has a 1-year low of $153.58 and a 1-year high of $218.66. The company has a debt-to-equity ratio of 17.94, a quick ratio of 0.55 and a current ratio of 0.66. The firm has a market cap of $317.67 billion, a PE ratio of 74.83, a PEG ratio of 1.62 and a beta of 0.56. The business's 50-day moving average price is $193.34 and its two-hundred day moving average price is $187.23.
Read Our Latest Research Report on ABBV
Tempus AI (TEM)
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
TEM traded down $2.05 during trading on Wednesday, reaching $66.86. The company had a trading volume of 10,240,111 shares, compared to its average volume of 6,146,336. The company has a market cap of $11.51 billion and a P/E ratio of -8.57. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI has a 12 month low of $22.89 and a 12 month high of $91.45. The business's fifty day moving average price is $48.99 and its 200 day moving average price is $51.30.
Read Our Latest Research Report on TEM
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
